Clinical trial · Observational
Bergamo Lymphoid Cancer Registry
NCT03131531CI-TRIAL-00074730recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This registry has been established to gain a better understanding of the clinical and biological characteristics and outcome of patients with lymphoid cancer
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hodgkin Lymphoma | Hodgkin Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Myeloma | Multiple Myeloma | ALIAS | 0.90 |
| Non Hodgkin Lymphoma | Non-Hodgkin Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Patient registry | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Hodgkin lymphoma
- interventionNames
- Other: Patient registry
- label
- Non-Hodgkin lymphoma
- interventionNames
- Other: Patient registry
- label
- Myeloma
- interventionNames
- Other: Patient registry
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 20 years
- description
- Analyzed for all patients as time from diagnosis to death as a result of any cause, stratified according to intervention and baseline characteristics
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female patients 18 years or older * Written informed consent * Confirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma Exclusion Criteria: \- Unconfirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
References
Publications (0)
Data not yet available
No reference posted for this study.